{
  "success": true,
  "pagesUsed": [
    7,
    8,
    9,
    11,
    12,
    13,
    19,
    20,
    21,
    24,
    25,
    26,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    41,
    42,
    43
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "Axicabtagene ciloleucel",
        "type": {
          "id": "bfe0a60f-f3a2-4529-9934-67f18ed4e1d0",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "7ad20a09-31e8-45f7-89b4-08fa0d3629dd",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Autologous T cells transduced with retroviral vector containing anti-CD19 CD28/CD3ζ chimeric antigen receptor (KTE-C19)",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Standard of Care (SOC) Therapy",
        "type": {
          "id": "4a50ebb8-e90e-4e61-81b7-690346eb1c55",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "role": {
          "id": "0947e564-d9a6-46a3-b2f1-2e796d29518b",
          "code": "C54129",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Comparator",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Second-line combination chemotherapy regimen (R-ICE, R-DHAP, R-ESHAP, or R-GDP) followed by HDT and ASCT for responders",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Fludarabine",
        "type": {
          "id": "384bff59-92b4-4ae2-ace0-5ef9fdd9bdb1",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "32e40b7d-eb9b-4429-9488-92d84e98746f",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Cyclophosphamide",
        "type": {
          "id": "0cfa385b-98eb-459d-a9b0-a17ff9ed202c",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "3b7861f0-0946-4368-bfb8-d492213db313",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel",
        "productIds": [
          "prod_4"
        ],
        "administrationIds": [
          "admin_4"
        ]
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "4254301e-9b16-41e1-8f6e-3fe59fd721a8",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "role": {
          "id": "6ab6aa55-9051-4acc-8a51-08faf1339394",
          "code": "C54127",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Background Therapy",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Bridging therapy for subjects with high disease burden at screening",
        "administrationIds": [
          "admin_5"
        ]
      },
      {
        "id": "int_6",
        "name": "Mesna",
        "type": {
          "id": "82b6d856-efe2-42fe-aeb6-61aa5a399f28",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "fdd311a3-02b9-4c5c-980c-9af4ecdec52b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Detoxifying agent used to prevent hemorrhagic cystitis induced by chemotherapy"
      },
      {
        "id": "int_7",
        "name": "G-CSF",
        "type": {
          "id": "ae1259e7-f242-4259-94bb-0344740b31f6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "fa0184b7-6603-4a96-b314-e079f82ca04c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Growth factor support for leukapheresis and prevention of chemotherapy delays/infection"
      },
      {
        "id": "int_8",
        "name": "Tocilizumab",
        "type": {
          "id": "797362dc-aa85-44a9-aa1f-5fc6d453431b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "5b7139f7-0e03-43f2-bc95-2c299966e19e",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Used for management of cytokine release syndrome (implied by hypersensitivity exclusion)"
      },
      {
        "id": "int_9",
        "name": "Systemic immunostimulatory agents",
        "type": {
          "id": "15a1fc2c-c141-4ab0-9aba-a13dbc348be5",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "f4b70338-c741-4950-a560-22a079274c54",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 6 weeks or 5 half-lives prior to first dose (e.g., interferon, IL-2)"
      },
      {
        "id": "int_10",
        "name": "Live, attenuated vaccine",
        "type": {
          "id": "4253e91f-bdbe-4ffd-919d-ef912ca98e24",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "f0bb944a-de03-4733-9411-e25b358caa05",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Prohibited within 6 weeks prior to initiation of study treatment"
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "Axicabtagene ciloleucel",
        "administrableDoseForm": {
          "id": "e5286832-37ad-4844-a690-c0b32779556a",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "6f950d76-d84c-4b89-a22d-5b67bd53bb00",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "ce63b74d-5be8-4b42-8220-618f1555bc8d",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Target dose 2 x 10^6 anti-CD19 CAR T cells/kg",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Kite Pharma, Inc."
      },
      {
        "id": "prod_2",
        "name": "Fludarabine",
        "administrableDoseForm": {
          "id": "5dfec79e-3eed-478c-a589-eb2bb8b2ba0b",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "884ccfdc-6fab-4ee0-9844-7e949ace5380",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "7a110950-b61c-4691-8fba-df358c308c84",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "30 mg/m2",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_3",
        "name": "Cyclophosphamide",
        "administrableDoseForm": {
          "id": "0bf8cbd0-5c4c-456d-9924-eeb1b1fda641",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "f20ba811-1876-493a-b37f-7dcbbbb505ef",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "cac7355a-ecd7-475d-bd63-6b0241e53039",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "500 mg/m2",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Not specified"
      },
      {
        "id": "prod_4",
        "name": "Rituximab",
        "administrableDoseForm": {
          "id": "8e705fc2-0844-4f85-bd21-0e8f5ac66060",
          "code": "C42945",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Injection",
          "standardCode": {
            "id": "af44f1ef-7158-4579-bd9b-924697a9fd33",
            "code": "C42945",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Injection",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "31ca76ba-eb18-48c7-8986-aa25dc2fc4c9",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "375 mg/m2",
        "substanceIds": [
          "sub_4"
        ],
        "manufacturer": "Not specified"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Axicabtagene ciloleucel infusion",
        "instanceType": "Administration",
        "dose": "2 x 10^6 anti-CD19 CAR T cells/kg",
        "doseFrequency": "Single infusion",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Single dose on Treatment Day 0"
      },
      {
        "id": "admin_2",
        "name": "Conditioning Chemotherapy (Fludarabine)",
        "instanceType": "Administration",
        "dose": "30 mg/m2/day",
        "doseFrequency": "Once daily",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "3 days (Day -5 to Day -3)"
      },
      {
        "id": "admin_3",
        "name": "Conditioning Chemotherapy (Cyclophosphamide)",
        "instanceType": "Administration",
        "dose": "500 mg/m2/day",
        "doseFrequency": "Once daily",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "3 days (Day -5 to Day -3)"
      },
      {
        "id": "admin_4",
        "name": "Bridging Therapy (Dexamethasone)",
        "instanceType": "Administration",
        "dose": "20 to 40 mg",
        "doseFrequency": "Daily",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "1 to 4 days"
      },
      {
        "id": "admin_5",
        "name": "R-ICE Regimen",
        "instanceType": "Administration",
        "dose": "Rituximab 375mg/m2; Ifosfamide 5g/m2; Carboplatin AUC 5; Etoposide 100mg/m2",
        "doseFrequency": "Every 2-3 weeks",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "2 or 3 cycles"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Axicabtagene ciloleucel",
        "instanceType": "Substance",
        "description": "Autologous anti-CD19 CAR T cells"
      },
      {
        "id": "sub_2",
        "name": "Fludarabine phosphate",
        "instanceType": "Substance",
        "description": "Synthetic purine nucleoside antimetabolite"
      },
      {
        "id": "sub_3",
        "name": "Cyclophosphamide",
        "instanceType": "Substance",
        "description": "Nitrogen mustard-derivative alkylating agent"
      },
      {
        "id": "sub_4",
        "name": "Sodium-2-mercaptoethane sulfonate",
        "instanceType": "Substance",
        "description": "Active ingredient in Mesna"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 10,
      "productCount": 4,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "Axicabtagene ciloleucel",
        "role": "Investigational Product",
        "description": "Autologous T cells transduced with retroviral vector containing anti-CD19 CD28/CD3ζ chimeric antigen receptor (KTE-C19)"
      },
      {
        "name": "Standard of Care (SOC) Therapy",
        "role": "Comparator",
        "description": "Second-line combination chemotherapy regimen (R-ICE, R-DHAP, R-ESHAP, or R-GDP) followed by HDT and ASCT for responders"
      },
      {
        "name": "Fludarabine",
        "role": "Investigational Product",
        "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel"
      },
      {
        "name": "Cyclophosphamide",
        "role": "Investigational Product",
        "description": "Conditioning chemotherapy for lymphodepletion prior to axicabtagene ciloleucel"
      },
      {
        "name": "Corticosteroids",
        "role": "Background Therapy",
        "description": "Bridging therapy for subjects with high disease burden at screening"
      },
      {
        "name": "Mesna",
        "role": "Concomitant Medication",
        "description": "Detoxifying agent used to prevent hemorrhagic cystitis induced by chemotherapy"
      },
      {
        "name": "G-CSF",
        "role": "Concomitant Medication",
        "description": "Growth factor support for leukapheresis and prevention of chemotherapy delays/infection"
      },
      {
        "name": "Tocilizumab",
        "role": "Concomitant Medication",
        "description": "Used for management of cytokine release syndrome (implied by hypersensitivity exclusion)"
      },
      {
        "name": "Systemic immunostimulatory agents",
        "role": "Concomitant Medication",
        "description": "Prohibited within 6 weeks or 5 half-lives prior to first dose (e.g., interferon, IL-2)"
      },
      {
        "name": "Live, attenuated vaccine",
        "role": "Concomitant Medication",
        "description": "Prohibited within 6 weeks prior to initiation of study treatment"
      }
    ],
    "products": [
      {
        "name": "Axicabtagene ciloleucel",
        "doseForm": "Injection",
        "strength": "Target dose 2 x 10^6 anti-CD19 CAR T cells/kg",
        "manufacturer": "Kite Pharma, Inc."
      },
      {
        "name": "Fludarabine",
        "doseForm": "Injection",
        "strength": "30 mg/m2",
        "manufacturer": "Not specified"
      },
      {
        "name": "Cyclophosphamide",
        "doseForm": "Injection",
        "strength": "500 mg/m2",
        "manufacturer": "Not specified"
      },
      {
        "name": "Rituximab",
        "doseForm": "Injection",
        "strength": "375 mg/m2",
        "manufacturer": "Not specified"
      }
    ],
    "substances": [
      {
        "name": "Axicabtagene ciloleucel",
        "description": "Autologous anti-CD19 CAR T cells"
      },
      {
        "name": "Fludarabine phosphate",
        "description": "Synthetic purine nucleoside antimetabolite"
      },
      {
        "name": "Cyclophosphamide",
        "description": "Nitrogen mustard-derivative alkylating agent"
      },
      {
        "name": "Sodium-2-mercaptoethane sulfonate",
        "description": "Active ingredient in Mesna"
      }
    ],
    "administrations": [
      {
        "name": "Axicabtagene ciloleucel infusion",
        "dose": "2 x 10^6 anti-CD19 CAR T cells/kg",
        "frequency": "Single infusion",
        "route": "Intravenous",
        "duration": "Single dose on Treatment Day 0"
      },
      {
        "name": "Conditioning Chemotherapy (Fludarabine)",
        "dose": "30 mg/m2/day",
        "frequency": "Once daily",
        "route": "Intravenous",
        "duration": "3 days (Day -5 to Day -3)"
      },
      {
        "name": "Conditioning Chemotherapy (Cyclophosphamide)",
        "dose": "500 mg/m2/day",
        "frequency": "Once daily",
        "route": "Intravenous",
        "duration": "3 days (Day -5 to Day -3)"
      },
      {
        "name": "Bridging Therapy (Dexamethasone)",
        "dose": "20 to 40 mg",
        "frequency": "Daily",
        "route": "Oral or Intravenous",
        "duration": "1 to 4 days"
      },
      {
        "name": "R-ICE Regimen",
        "dose": "Rituximab 375mg/m2; Ifosfamide 5g/m2; Carboplatin AUC 5; Etoposide 100mg/m2",
        "frequency": "Every 2-3 weeks",
        "route": "Intravenous",
        "duration": "2 or 3 cycles"
      }
    ],
    "devices": []
  }
}